The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
CD44 as a potential diagnostic tumor marker
Open accessAbstract
CD44 is a cellular protein that has been intensively studied in relation to carcinogenesis over the last decade. It is altered during inflammatory responses and cellular malfunctioning during tumor progression. Tumors of epithelial origin express CD44 in multiple isoforms called variants; some isoforms are related to specific cancer cells. An increase of CD44 specific isoforms is detected in certain leukemic proliferations. Most published data indicates a partial involvement of CD44 in cancer cells, either in invasiveness or self-renewability. However, there is still uncertainty regarding the exact mechanism by which CD44 participates in growth of cancer or the inflammatory response. This review focuses on CD44 prevalence in cancer cell. It considers tumorigenic behavior of cells that highly express CD44 as an early marker for neoplastic stem cell proliferation. We will discuss multiple examples of tumor in this paper, with an emphasis of 2 solid tumors; namely, breast and colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
Integrins and the actin cytoskeleton
Delon, I., & Brown, N. H. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.12.013 · Cited by 249
Cited by
Senbanjo, L. T., & Chellaiah, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00018 · Cited by 842
Collagen- and hyaluronic acid-based hydrogels and their biomedical applications
Xu, Q., Torres, J. E., Hakim, M., Babiak, P. M., Pal, P., Battistoni, C. M., Nguyen, M., Panitch, A., Solorio, L., & Liu, J. C. (2021) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2021.100641 · Cited by 318
Cancer stem cells in colorectal cancer: a review
Munro, M. J., Wickremesekera, S. K., Peng, L., Tan, S. T., & Itinteang, T. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204739 · Cited by 304
Cancer Targeting and Drug Delivery Using Carbon-Based Quantum Dots and Nanotubes
Pardo, J., Peng, Z., & Leblanc, R. (2018) · Molecules · doi:10.3390/molecules23020378 · Cited by 226
Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
Mohanty, A., Uthaman, S., & Park, I.-K. (2020) · Molecules · doi:10.3390/molecules25194377 · Cited by 160
Metadata
- Authors
- Basakran, N. S.
- Venue
- Saudi Medical Journal
- Publisher
- Saudi Medical Journal
- Published
- 2015-03
- Volume
- 36
- Issue
- 3
- Pages
- 273-279
- ISSN
- 0379-5284 (ISSN-L)
- 1658-3175
- OpenAlex
- W2114220759
- Cited by
- 175
- References
- 2
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD44 as a potential diagnostic tumor marker. https://app.cochat.ai/papers/10.15537/smj.2015.3.9622
- The paper
- Basakran, N. S. (2015). CD44 as a potential diagnostic tumor marker. Saudi Medical Journal. https://doi.org/10.15537/smj.2015.3.9622
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.